Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib vs Sorafenib in Advanced Hepatocellular Carcinoma
NCT00699374Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jul 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 23
01
Overview
A Phase 3 trial of sunitinib in hepatocellular carcinoma (HCC), sponsored by Pfizer. Started Jul 2008; status: terminated.
02
Drugs
sunitinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00699374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699374.